Ji Zhou - Concepedia

Author

Ji Zhou

Swedish University of Agricultural Sciences ORCID

Also Known As

J Zhou, J. Zhou, J.Q. Zhou, JI ZHOU, Ji Zhou, Zhou Ji

Publications

807

Citations

H-Index

Concepts

All Affiliations

Swedish University of Agricultural Sciences Central South University Jiangxi Provincial People's Hospital Fujian Provincial Cancer Hospital People's Liberation Army 411 Hospital

About

Ji Zhou is an author at Swedish University of Agricultural Sciences specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	228
2	Cell Biology	2	2	84
3	Immunology	2	2	109
4	Health Sciences	1	1	23
5	Nephrology	1	1	21

Ji Zhou

Publications

544

Citations

H-Index

Page 1

	Year	Citations
Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1 Chuanjing Wu, Rongjiang Yang, Ji Zhou, Journal of Immunological Methods Autoimmune DiseaseImmunologyAntigen ProcessingAutoimmunityPeptide Science	2003	68
Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay Zhi Heng Chen, Shou Qing Huang, Yande Wang, Sensors	2011	57
Thymidine Kinase 1 is a Potential Marker for Prognosis and Monitoring the Response to Treatment of Patients with Breast, Lung, and Esophageal Cancer and Non-Hodgkin's Lymphoma Ellen He, Xin-Rong Xu, Hong Guan, Nucleosides Nucleotides & Nucleic Acids	2010	57
Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings Yan Chen, Mingang Ying, YanSong Chen, International Journal of Clinical Oncology MedicinePathologyImmune Checkpoint InhibitorClinical ReactionsClinical Stages	2010	45
Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients Zhu-Lin Pan, Xing-ying Ji, Yanmin Shi, Journal of Cancer Research and Clinical Oncology Lymphoid NeoplasiaPrognostic FactorMedicineImmunologyPathology	2010	41
Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people Yu Wang, Xiaorong Jiang, Dong Shao-liang, Cancer Biomarkers	2016	40
Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours. Zhiheng Chen, Hui Zhou, Shenglan Li, PubMed	2009	37
Role of ultrasound in the differentiation of parathyroid carcinoma and benign parathyroid lesions Jinyue Liu, Weiwei Zhan, Ji Zhou, Clinical Radiology Medical UltrasoundBenign Parathyroid LesionsParathyroid HormoneParathyroid DiseaseParathyroid Gland	2019	29
Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling Yongrong Mao, Jainping Wu, Sven Skog, Oncology Reports	2005	25
Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer Feiyu Chen, Lili Tang, Ting Xia, Molecular and Clinical Oncology	2013	24

Page 1